ArticleBiomedical reports2021

Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease.

Satoshi Shinozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.